A股增量市场确立资金共识将聚焦两大方向

Core Viewpoint - The A-share market is transitioning from a stock game to an incremental market, driven by significant improvements in capital inflow and supportive macro policies [2][6]. Capital Inflow and Market Transition - The capital inflow scale has significantly improved, with various types of funds, including public funds, quantitative funds, and insurance, showing synchronized incremental inflows [2][3]. - The shift from net outflows to net inflows in active public funds is expected to occur by June 2025, indicating a gradual transition to an incremental market [2][3]. Investment Strategy Shift - Investors are advised to shift from short-term trading strategies to holding strategies, as the attractiveness of core assets with high economic resilience is expected to rise [2][3]. - The focus should be on sectors with low valuations and high resilience, such as overseas markets and Hang Seng Technology, which are anticipated to become key allocation directions for incremental funds [2][6]. Sector Rotation and Opportunities - Key sectors for investment include Hang Seng Technology, non-ferrous metals, and AI, each with unique investment logic and clear rotation rhythms [4][5]. - The Hang Seng Technology sector is expected to benefit from multiple catalysts, including the domestic application of AI and optimization of domestic computing power capacity [4][5]. Emerging Trends in Overseas Markets - The overseas market is seen as a new direction for investment, with significant potential for companies in the export chain to exceed performance expectations [3][4]. - Historical data indicates that overseas expansion significantly enhances companies' return on equity (ROE) and profit margins, although this potential has not yet been fully priced in by the market [3][4]. Focus on AI and Innovative Pharmaceuticals - The AI and innovative pharmaceuticals sectors are highlighted as core investment directions due to their clear industry trends and growth potential [5][6]. - The AI sector is experiencing a positive cycle driven by increased reasoning computing power and user engagement, while innovative pharmaceuticals are positioned as a resilient sector amid economic fluctuations [5][6].